LS Investment Advisors’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,934
| Closed | -$249K | – | 1757 |
|
|
2019
Q4 | $249K | Buy |
2,934
+757
| +35% | +$50.5K | 0.01% | 715 |
|
|
2019
Q3 | $109K | Hold |
2,177
| – | – | 0.01% | 1045 |
|
|
2019
Q2 | $79K | Hold |
2,177
| – | – | ﹤0.01% | 1165 |
|
|
2019
Q1 | $61K | Hold |
2,177
| – | – | ﹤0.01% | 1249 |
|
|
2018
Q4 | $42K | Hold |
2,177
| – | – | ﹤0.01% | 1320 |
|
|
2018
Q3 | $65K | Sell |
2,177
-41
| -2% | -$1.54K | ﹤0.01% | 1249 |
|
|
2018
Q2 | $81K | Hold |
2,218
| – | – | ﹤0.01% | 1194 |
|
|
2018
Q1 | $73K | Buy |
2,218
+73
| +3% | +$2.28K | ﹤0.01% | 1190 |
|
|
2017
Q4 | $59K | Sell |
2,145
-463
| -18% | -$14.3K | ﹤0.01% | 1263 |
|
|
2017
Q3 | $97K | Sell |
2,608
-253
| -9% | -$9.33K | 0.01% | 1164 |
|
|
2017
Q2 | $109K | Hold |
2,861
| – | – | 0.01% | 1108 |
|
|
2017
Q1 | $140K | Sell |
2,861
-122
| -4% | -$5.56K | 0.01% | 1000 |
|
|
2016
Q4 | $101K | Buy |
2,983
+41
| +1% | +$1.45K | 0.01% | 1039 |
|
|
2016
Q3 | $111K | Buy |
2,942
+51
| +2% | +$1.92K | 0.01% | 979 |
|
|
2016
Q2 | $97K | Buy |
2,891
+172
| +6% | +$6.06K | 0.01% | 1008 |
|
|
2016
Q1 | $86K | Buy |
2,719
+209
| +8% | +$6.83K | 0.01% | 938 |
|
|
2015
Q4 | $94K | Hold |
2,510
| – | – | 0.01% | 884 |
|
|
2015
Q3 | $95K | Hold |
2,510
| – | – | 0.01% | 867 |
|
|
2015
Q2 | $72K | Buy |
+2,510
| New | +$69.9K | 0.01% | 1024 |
|
Other funds holding MDCO
LS Investment Advisors's MDCO Position: Q1 2020 in Review
LS Investment Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 2,934 shares — an estimated $249K sold.
LS Investment Advisors first reported a position in MDCO in Q2 2015 and held it in 19 quarters. The position peaked at $249K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- LS Investment Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- LS Investment Advisors sold 2,934 Medicines Co shares in Q1 2020, an estimated $249K.
- LS Investment Advisors first reported a position in Medicines Co in Q2 2015 and held it in 19 quarters.
- LS Investment Advisors's Medicines Co position peaked at $249K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on LS Investment Advisors's 13F filing for Q1 2020, filed 20 Apr 2020.